Breast cancer future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
==Adoptive cell therapy== | ==Adoptive cell therapy== | ||
Generally, cancer immunotherapy refers to immune checkpoint inhibitors and cytokines, adoptive cell therapy, and cancer vaccines. | |||
===Cancer vaccines=== | |||
==I-SPY 2 clinical trial== | ==Personalized medicine and I-SPY 2 clinical trial== | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
Revision as of 18:42, 26 April 2019
Immunotherapeutic interventions
Adoptive cell therapy
Generally, cancer immunotherapy refers to immune checkpoint inhibitors and cytokines, adoptive cell therapy, and cancer vaccines.